Trofinetide Patent Expiration
Trofinetide is Used for treating Rett Syndrome or its symptoms. It was first introduced by Acadia Pharmaceuticals Inc
Trofinetide Patents
Given below is the list of patents protecting Trofinetide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Daybue | US11827600 | Crystalline forms of trofinetide | Jul 12, 2042 | Acadia Pharms Inc |
| Daybue | US11370755 | Compositions of trofinetide | Aug 03, 2040 | Acadia Pharms Inc |
| Daybue | US9212204 | Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid | Jan 27, 2032 | Acadia Pharms Inc |
Trofinetide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List